Nature Communications (Nov 2020)
In vitro-transcribed antigen receptor mRNA nanocarriers for transient expression in circulating T cells in vivo
Abstract
Ex vivo engineering of antigen-specific T cells has shown therapeutic efficacy but can be costly and scarce. Here the authors show that in vitro-transcribed antigen receptor mRNA packaged in nanocarriers can directly induce, in vivo, transient their expression in circulating T cells to provide therapeutic effects in mouse models of cancer or viral infection.